Article

An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy

2023-04-19

Abstract excerpt

<h4>ABSTRACT</h4> COVID-19 has claimed millions of lives since the emergence of SARS-CoV-2, and lung disease appears the primary cause of the death in COVID-19 patients. However, the underlying mechanisms of COVID-19 pathogenesis remain elusive, and there is no existing model where the human disease can be faithfully recapitulated and conditions for the infection process can be experimentally controlled. Herein w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d7693c6d-cfca-5f29-9fa2-2a7de11d050f
DOI: 10.1101/2023.04.18.537373

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacyDOI 10.1101/2023.04.18.537373Read

An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacySemantic proximity Read

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung OrganoidsSemantic proximity Read

Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19Semantic proximity Read

A precision-cut lung slice platform for evaluating respiratory virus replication dynamicsSemantic proximity Read

Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19Semantic proximity Read

Human airway organoids model SARS-CoV-2 high infectiousness and evasion of interferon responseSemantic proximity Read

COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosisSemantic proximity Read

A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquineSemantic proximity Read

Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responsesSemantic proximity Read

PANoptosis as a Therapeutic Target for COVID-19Semantic proximity Read

Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue CellsSemantic proximity Read

<i>In vitro</i> infection of human lung tissue with SARS-CoV-2: Heterogeneity in host defense and therapeutic responseSemantic proximity Read